Protease-Activated Receptor-2 Antagonists and Agonists
Journal:
Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume:
1
Page:
73-82
Author(s):
Robert M. Scarborough
The Prodigiosins: A New Family of Anticancer Drugs
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
57-65
Author(s):
Beatriz Montaner and Ricardo Pérez-Tomás
Anti-Interleukin-6 Therapy for Crohns Disease
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
295-305
Author(s):
H. Ito
Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
307-321
Author(s):
Koji Sawada, Tetsuichiro Muto, Takashi Shimoyama, Masamichi Satomi, Toshio Sawada, Hirokazu Nagawa, Nobuo Hiwatashi, Hitoshi Asakura and Toshifumi Hibi
Role of Dietary Fiber and Short-Chain Fatty Acids in the Colon
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
347-358
Author(s):
Akira Andoh, Tomoyuki Tsujikawa and Yoshihide Fujiyama
Recent Advances in Peroxisome Proliferator-Activated Receptor Science
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
267-280
Author(s):
Barry G. Shearer and William J. Hoekstra
Prediction of Biological Activity Spectra for Substances: Evaluation on the Diverse Sets of Drug-Like Structures
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
225-233
Author(s):
A. V. Stepanchikova, A. A. Lagunin, D. A. Filimonov and V. V. Poroikov
Imino-Sugar-Based Nucleosides
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
525-540
Author(s):
Vern L. Schramm and Peter C. Tyler
Probiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
175-191
Author(s):
A. Mercenier, S. Pavan and B. Pot
Cytokines in the Pathogenesis of Chronic Obstructive Pulmonary Disease
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
25-38
Author(s):
P. T. Reid and J.- M. Sallenave